Cell Therapy Technologies Market Growth, Size, Trends Analysis - By Product, By Process, By Cell Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034

Description

Cell Therapy Technologies Market Introduction and Overview

According to SPER market research, 'Global Cell Therapy Technologies Market Size- By Product, By Process, By Cell Type, By Application, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Cell Therapy Technologies Market is predicted to reach 7.64 billion by 2030 with a CAGR of 11.25%.

The application of machine learning and computational algorithms to the analysis and interpretation of diagnostic data is known as artificial intelligence (AI) in in-vitro diagnostics (IVD). This is done to enhance clinical decision-making, accuracy, and efficiency in laboratory testing and medical diagnostics. Diabetes, heart disease, and cancer are among the chronic illnesses that are becoming more prevalent globally. AI is being used more and more to enhance the effectiveness, accuracy, and customized treatment options for a range of illnesses.

Autologous therapies, such as CAR-T, need extremely low temperatures of -196°C to keep cells alive during production and delivery. Any disruption in temperature can lower the effectiveness of the treatment, risking both health and money. Companies like Cryoport help with this process, but their advanced systems raise shipping costs, making treatment less accessible. Additionally, delays in transporting patient-specific cells to and from manufacturing facilities can impact timely treatment.

Scope of the report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Product, By Process, By Cell Type, By Application, By End User

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered Danaher Corporation, Merck KGaA, Thermo Fisher Scientific Inc, Lonza, Sartorius AG, Agilent Technologies, Inc, Bio-Techne, Avantor, Inc, Genscript, BD, Corning Incorporated.

Cell Therapy Technologies Market Segmentation:

By Product: Based on the Product, Global Cell Therapy Technologies Market is segmented as; Media, Sera & Reagents, Cell Engineering Products, Cell Culture Vessels, Cell Therapy Equipment, Systems & Software, and Other Products.

By Process: Based on the Process, Global Cell Therapy Technologies Market is segmented as; Cell Processing, Cell Preservation, Cell Distribution, Cell Handling, Process Monitoring & Quality Control.

By Cell Type: Based on the Cell Type, Global Cell Therapy Technologies Market is segmented as; T-Cells, Stem Cells, Other Cells.

By Application: Based on the Application, Global Cell Therapy Technologies Market is segmented as; Cancer, Cardiovascular Disease, Orthopedic Disorders, Autoimmune Diseases, Other Applications.

By End User: Based on the End User, Global Cell Therapy Technologies Market is segmented as; Biopharmaceutical and Biotechnology Companies, CROs and CMOs, Research Institutes, Cell Banks.

Product Code: HLCA2503

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Cell Therapy Technologies Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Cell Therapy Technologies Market

7. Global Cell Therapy Technologies Market, By Product (USD Million) 2021-2034

7.1. Media
7.2. Sera & Reagents,
7.3. Cell Engineering Products
7.4. Cell Culture Vessels
7.5. Cell Therapy Equipment
7.6. Systems & Software
7.7. Other Products

8. Global Cell Therapy Technologies Market, By Process (USD Million) 2021-2034

8.1. Cell Processing
8.2. Cell Preservation
8.3. Cell Distribution
8.4. Cell Handling
8.5. Process Monitoring & Quality Control

9. Global Cell Therapy Technologies Market, By Cell type (USD Million) 2021-2034

9.1. T-Cells
9.2. Stem cells

10. Global Cell Therapy Technologies Market, By Application (USD Million) 2021-2034

10.1. Cancer
10.2. Cardiovascular disease (CVD)
10.3. Orthopaedic disorders
10.4. Autoimmune diseases
10.5. Other applications

11. Global Cell Therapy Technologies Market, By End User (USD Million) 2021-2034

11.1. Biopharmaceutical & Biotechnology Companies
11.2. CROs & CMOs
11.3. Research Institutes
11.4. Cell Banks

12. Global Cell Therapy Technologies Market (USD Million) 2021-2034

12.1. Global Cell Therapy Technologies Market Size and Market Share

13. Global Cell Therapy Technologies Market, By Region (USD Million) 2021-2034

13.1. Asia-Pacific
- 13.1.1. Australia
- 13.1.2. China
- 13.1.3. India
- 13.1.4. Japan
- 13.1.5. South Korea
- 13.1.6. Rest of Asia-Pacific
13.2. Europe
- 13.2.1. France
- 13.2.2. Germany
- 13.2.3. Italy
- 13.2.4. Spain
- 13.2.5. United Kingdom
- 13.2.6. Rest of Europe
13.3. Middle East and Africa
- 13.3.1. Kingdom of Saudi Arabia
- 13.3.2. United Arab Emirates
- 13.3.3. Qatar
- 13.3.4. South Africa
- 13.3.5. Egypt
- 13.3.6. Morocco
- 13.3.7. Nigeria
- 13.3.8. Rest of Middle-East and Africa
13.4. North America
- 13.4.1. Canada
- 13.4.2. Mexico
- 13.4.3. United States
13.5. Latin America
- 13.5.1. Argentina
- 13.5.2. Brazil
- 13.5.3. Rest of Latin America

14. Company Profile

14.1. Danaher Corporation
- 14.1.1. Company details
- 14.1.2. Financial outlook
- 14.1.3. Product summary
- 14.1.4. Recent developments
14.2. Merck KGaA
- 14.2.1. Company details
- 14.2.2. Financial outlook
- 14.2.3. Product summary
- 14.2.4. Recent developments
14.3. Thermo Fisher Scientific Inc
- 14.3.1. Company details
- 14.3.2. Financial outlook
- 14.3.3. Product summary
- 14.3.4. Recent developments
14.4. Lonza
- 14.4.1. Company details
- 14.4.2. Financial outlook
- 14.4.3. Product summary
- 14.4.4. Recent developments
14.5. Sartorius AG
- 14.5.1. Company details
- 14.5.2. Financial outlook
- 14.5.3. Product summary
- 14.5.4. Recent developments
14.6. Agilent Technologies, Inc
- 14.6.1. Company details
- 14.6.2. Financial outlook
- 14.6.3. Product summary
- 14.6.4. Recent developments
14.7. Bio-Techne
- 14.7.1. Company details
- 14.7.2. Financial outlook
- 14.7.3. Product summary
- 14.7.4. Recent developments
14.8. Avantor, Inc
- 14.8.1. Company details
- 14.8.2. Financial outlook
- 14.8.3. Product summary
- 14.8.4. Recent developments
14.9. Genscript
- 14.9.1. Company details
- 14.9.2. Financial outlook
- 14.9.3. Product summary
- 14.9.4. Recent developments
14.10. BD
- 14.10.1. Company details
- 14.10.2. Financial outlook
- 14.10.3. Product summary
- 14.10.4. Recent developments
14.11. Corning Incorporated
- 14.11.1. Company details
- 14.11.2. Financial outlook
- 14.11.3. Product summary
- 14.11.4. Recent developments
14.12. Others